Kenya Risks Losing Millions From Global Fund Over Corruption
The Global Fund says Kenya risks losing over U.S.$445 million aimed at boosting the fight against HIV, tuberculosis and malaria in the country, if corruption allegations at the Kenya Medical Supplies Authority (Kemsa) are not completed and changes made to ensure transparency.
The Ethics and Anti-Corruption Commission began investigating allegations of graft at Kemsa in 2020 over the procurement and supply of Covid-19 equipment. The agency cited an "irregular expenditure" of U.S.$72 million.
To continue receiving grants, Kemsa is expected to finish implementation of reforms so that they can make urgent interventions, including addressing recent disruptions in the supply of critical HIV drugs.
The Kenyan government has abandoned its demand that it should be the sole distributor of a U.S.$19 million consignment of HIV drugs donated by the U.S., ending a six-month standoff ... Read more »
The Council of Governors and the Global Fund has admitted that Lopinavir/Ritonavir syrup is out of stock and that the country is awaiting emergency supplies. Children with HIV will ... Read more »
The board of directors of the Kenya Medical Supplies Authority (KEMSA) has been disbanded in the wake of multi-billion-shilling tendering scandals plaguing the medical supplies ... Read more »
Due to ongoing corruption investigations, the Ethics and Anti-Corruption Commission officials took all the records at Kenya Medical Supplies Agency (Kemsa) and stopped payments ... Read more »
The names and faces of officials who may have been involved in Covid-19 corruption are being revealed as investigations gather steam. President Uhuru Kenyatta has in the meantime ... Read more »
The Kenya Medical Supplies Authority's offices in Industrial Area, Nairobi.